# Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment

> **NCT01386983** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 332 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** 5ARI
- **DRUG:** 5ARI + AB

## Key facts

- **NCT ID:** NCT01386983
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 332 (ACTUAL)
- **Last updated:** 2017-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386983, "Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01386983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*